Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice

• Published in: International journal of nanomedicine Vol. 15; pp. 3877 - 3886
• Main Authors: Sadeghi, Zohre, Fasihi-Ramandi, Mahdi, Bouzari, Saeid
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01-01-2020; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Abortion; adjuvant; Adjuvants, Immunologic - administration & dosage; Adjuvants, Immunologic - pharmacology; Animals; Antibodies; Antigenic determinants; Antigens; Antigens, Bacterial - chemistry; Bacterial Proteins - immunology; brucella; Brucella abortus - immunology; Brucella melitensis - immunology; Brucella Vaccine - chemistry; Brucella Vaccine - immunology; Brucellosis; Brucellosis - immunology; Brucellosis - prevention & control; Calcium phosphate; calcium phosphate nanoparticle; Calcium phosphates; Calcium Phosphates - chemistry; Cytokines; Deoxyribonucleic acid; DNA; Drug Delivery Systems; E coli; Female; Immune response; Immunity, Humoral; Immunization; Immunoglobulin G; Immunoglobulin G - immunology; Life sciences; Membrane Transport Proteins - immunology; Mice, Inbred BALB C; Nanoparticles; Nanoparticles - chemistry; Original Research; Plasmids; Proteins; vaccine; Vaccines; Iran; United Kingdom > UK; United States > US; vaccine; adjuvant; immune response; calcium phosphate nanoparticle; Brucella
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S249942

Vaccine formulation with appropriate adjuvants is an attractive approach to develop protective immunity against pathogens. Calcium phosphate nanoparticles (CaPNs) are considered as ideal adjuvants and delivery systems because of their great potential for enhancing immune responses. In the current study, we have designed nanoparticle-based vaccine candidates to induce immune responses and protection against
and
.
For this purpose, we used three
antigens (FliC, 7α-HSDH, BhuA) and two multi-epitopes (poly B and poly T) absorbed by CaPNs. The efficacy of each formulation was evaluated by measuring humoral, cellular and protective responses in immunized mice.
The CaPNs showed an average size of about 90 nm with spherical shape and smooth surface. The CaPNs-adsorbed proteins displayed significant increase in cellular and humoral immune responses compared to the control groups. In addition, our results showed increased ratio of specific IgG2a (associated with Th1) to specific IgG1 (associated with Th2). Also, immunized mice with different vaccine candidate formulations were protected against
16M and
544, and showed same levels of protection as commercial vaccines (
Rev.1 and
RB51) except for BhuA-CaPNs.
Our data support the hypothesis that these antigens absorbed with CaPNs could be effective vaccine candidates against
and
.